Klaus Überla
klausueberla.bsky.social
Klaus Überla
@klausueberla.bsky.social
Virus and vaccine research, Head Virology Institute Erlangen, Speaker Research Training Grant "Novel antiviral strategies"
Starker und wichtiger Beitrag!
June 4, 2025 at 3:44 PM
Decree of which Organisation?
February 6, 2025 at 8:08 AM
Die Folge: mehr HIV Neuinfektionen, mehr HIV Resistenzen, mehr Infektionen mit opportunistischen Erregern
January 29, 2025 at 10:15 PM
Great review experience at Plos Pathogens with great comments from the reviewers "The authors slightly modified an ingenious and elegant system, first reported in the Stab et al CRM 2023 manuscript“ (doi: 10.1016/j.xcrm.2023.101201)"
journals.plos.org/plospathogen...
December 27, 2024 at 9:38 AM
Elie Richel now shows in a preclinical HIV model that monoclonal antibodies can do this this by neutralization, but not by Fc-effector functions.
December 27, 2024 at 9:35 AM
Best way to protect individuals from viruses is to block entry of viruses into the very first cells at the exposed mucosal site. Most important for HIV, since this avoids establishment of latently infected cells, that may reactivate the virus years later.
December 27, 2024 at 9:34 AM
Hi Erik,
I am a virologist and would like to contribute to the Science🧪 feed. Here the link to my lab: www.virologie.uk-erlangen.de/en/research/...
Thank you
Klaus
Research Group of K. Überla - Virologie | Uniklinikum Erlangen
www.virologie.uk-erlangen.de
December 27, 2024 at 8:29 AM